Hematology and Blood Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +32-28-08-6657

Short Communication - Hematology and Blood Disorders (2020) Volume 3, Issue 1

Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy

Diffuse large B-cell lymphoma (DLBCL) is the most aggressive and common form of non-Hodgkin lymphoma. DLBCL arises during B-cell development in the germinal center reaction as a result of high levels of genomic rearrangements to create high affinity B-cell receptors. Therefore, an important hallmark of DLBCL is the high levels of genomic instability; DNA damage and DNA damage response proteins

Author(s): Tom van Meerten, Mathilde Rikje Willemijn de Jong, Lydia Visser

Abstract Full Text PDF